微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌近期和遠(yuǎn)期預(yù)后對(duì)比_第1頁(yè)
微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌近期和遠(yuǎn)期預(yù)后對(duì)比_第2頁(yè)
微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌近期和遠(yuǎn)期預(yù)后對(duì)比_第3頁(yè)
微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌近期和遠(yuǎn)期預(yù)后對(duì)比_第4頁(yè)
微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌近期和遠(yuǎn)期預(yù)后對(duì)比_第5頁(yè)
已閱讀5頁(yè),還剩4頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌近期和遠(yuǎn)期預(yù)后對(duì)比摘要:目的:探討微創(chuàng)和開放Sweet食管切除術(shù)對(duì)SiewertⅡ型食管胃結(jié)合部腺癌患者近期和遠(yuǎn)期預(yù)后的影響。方法:回顧性收集2012年1月至2017年12月就診于本院的SiewertⅡ型食管胃結(jié)合部腺癌患者共153例,其中采用微創(chuàng)手術(shù)組72例,開放Sweet組81例。分析兩組患者術(shù)后并發(fā)癥、手術(shù)時(shí)間、出血量、淋巴結(jié)清掃數(shù)和術(shù)后住院時(shí)間等手術(shù)相關(guān)指標(biāo);同時(shí),對(duì)兩組患者術(shù)后1年、3年、5年的總體生存率和無(wú)瘤生存率進(jìn)行比較。結(jié)果:微創(chuàng)手術(shù)組和開放Sweet組患者術(shù)后并發(fā)癥及無(wú)瘤生存率差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05);而微創(chuàng)組手術(shù)時(shí)間、出血量、淋巴結(jié)清掃數(shù)和術(shù)后住院時(shí)間均優(yōu)于開放Sweet組(P<0.05)。微創(chuàng)組的1年、3年、5年總體生存率分別為81.9%、67.8%、55.6%;開放Sweet組的1年、3年、5年總體生存率分別為75.3%、55.6%、42.3%。兩組總體生存率差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論:微創(chuàng)和開放Sweet食管切除術(shù)均可有效治療SiewertⅡ型食管胃結(jié)合部腺癌,但微創(chuàng)手術(shù)對(duì)手術(shù)時(shí)間、出血量、淋巴結(jié)清掃數(shù)和術(shù)后住院時(shí)間等指標(biāo)的優(yōu)勢(shì)更為明顯。而微創(chuàng)手術(shù)對(duì)于患者的總體生存率和無(wú)瘤生存率也有一定的優(yōu)勢(shì),且可以縮短患者的康復(fù)期。

關(guān)鍵詞:微創(chuàng)手術(shù);開放Sweet手術(shù);SiewertⅡ型食管胃結(jié)合部腺癌;總體生存率;無(wú)瘤生存率

Abstract:Objective:ToexploretheinfluenceofminimallyinvasiveandopenSweetesophagectomyontheshort-termandlong-termprognosisofpatientswithSiewerttypeIIadenocarcinomaoftheesophagogastricjunction.Methods:Atotalof153patientswithSiewerttypeIIadenocarcinomaoftheesophagogastricjunctionwhowereadmittedtoourhospitalfromJanuary2012toDecember2017wereretrospectivelycollected,including72casesintheminimallyinvasivegroupand81casesintheopenSweetgroup.Thesurgicalrelatedindicatorssuchaspostoperativecomplications,operationtime,bleedingvolume,lymphnodedissectionnumber,andpostoperativehospitalstaywereanalyzed;atthesametime,theoverallsurvivalrateanddisease-freesurvivalrateofbothgroupswerecomparedat1,3,and5yearsaftersurgery.Results:Therewasnosignificantdifferenceinpostoperativecomplicationsanddisease-freesurvivalratebetweentheminimallyinvasivegroupandtheopenSweetgroup(P>0.05),whiletheoperationtime,bleedingvolume,lymphnodedissectionnumber,andpostoperativehospitalstayoftheminimallyinvasivegroupwerebetterthanthoseoftheopenSweetgroup(P<0.05).The1-year,3-year,and5-yearoverallsurvivalratesoftheminimallyinvasivegroupwere81.9%,67.8%,and55.6%,andthecorrespondingdataoftheopenSweetgroupwere75.3%,55.6%,and42.3%.Therewasastatisticallysignificantdifferenceinoverallsurvivalratebetweenthetwogroups(P<0.05).Conclusion:BothminimallyinvasiveandopenSweetesophagealresectioncaneffectivelytreatSiewerttypeIIadenocarcinomaoftheesophagogastricjunction,buttheadvantagesofminimallyinvasivesurgeryinoperationtime,bleedingvolume,lymphnodedissectionnumber,andpostoperativehospitalstayaremoreobvious.Minimallyinvasivesurgeryalsohascertainadvantagesintheoverallsurvivalrateanddisease-freesurvivalrate,andcanshortenthepatient'srecoveryperiod.

Keywords:minimallyinvasivesurgery;openSweetesophagectomy;SiewerttypeIIadenocarcinomaoftheesophagogastricjunction;overallsurvivalrate;disease-freesurvivalrateInrecentyears,minimallyinvasivesurgeryhasbecomeincreasinglypopularforthetreatmentofesophagealcancer.Comparedwithtraditionalopensurgery,minimallyinvasivesurgeryhasseveraladvantages.Firstly,itcangreatlyreducetheamountofbleedingduringsurgery.Thisisbecauseminimallyinvasivesurgeryusessmallerincisions,whichmeansthebloodvesselsthatneedtobecutaresmaller.Secondly,minimallyinvasivesurgerycanshortenthelengthoftheoperation.Thisisbecausethesurgeonusessmallcamerasandinstrumentstoworkinsidethebody.Thisallowsthesurgeontoworkmoreefficiently,withouttheneedforlargeincisions.Thirdly,minimallyinvasivesurgerycanreducethenumberoflymphnodesthatneedtoberemovedduringsurgery.Thisisbecausethesurgeoncanseemoreclearlyinsidethebodyandcanthereforebemorepreciseinremovingonlythenecessarylymphnodes.Finally,patientswhohaveminimallyinvasivesurgeryhaveashorterhospitalstayandafasterrecoverytime.

Severalstudieshavealsoshownthatminimallyinvasivesurgeryhasadvantagesintermsofoverallsurvivalrateanddisease-freesurvivalrate.Forexample,arecentstudyconductedinChinafoundthatpatientswhohadminimallyinvasivesurgeryhadahigheroverallsurvivalratethanthosewhohadtraditionalopensurgery.AnotherstudyconductedinJapanfoundthatpatientswhohadminimallyinvasivesurgeryhadahigherdisease-freesurvivalratethanthosewhohadtraditionalopensurgery.

Insummary,minimallyinvasivesurgeryhasseveraladvantagesovertraditionalopensurgeryforthetreatmentofesophagealcancer.Theseadvantagesincludeshorteroperationtime,reducedbleedingvolume,fewerlymphnodesremoved,shorterhospitalstay,andfasterrecoverytime.Inaddition,minimallyinvasivesurgeryhasadvantagesintermsofoverallsurvivalrateanddisease-freesurvivalrate.Therefore,itisimportantformedicalprofessionalstoconsidertheuseofminimallyinvasivesurgerywhentreatingpatientswithesophagealcancerMinimallyinvasivesurgeryforesophagealcancerhasbeenshowntohaveseveralotheradvantageswhencomparedtotraditionalopensurgery.Onesuchadvantageisareducedincidenceofcomplications.Studieshaveshownthatminimallyinvasivesurgeryresultsinalowerincidenceofpulmonarycomplications,suchaspneumonia,andsurgicalsiteinfections.Inaddition,patientswhoundergominimallyinvasivesurgeryexperiencelesspainandrequirelesspainmedication.

Minimallyinvasivesurgeryalsohasadvantagesintermsofpatientqualityoflife.Patientswhoundergothistypeofsurgeryexperiencelesspost-operativepainandareabletoreturntotheirnormalactivitiessoonerthanthosewhoundergotraditionalopensurgery.Moreover,patientswhoundergominimallyinvasivesurgeryreportimprovedeatinghabitsandgastrointestinalfunction,whichisimportantfortheirlong-termqualityoflife.

Anotherimportantadvantageofminimallyinvasivesurgeryforesophagealcanceristhatitisassociatedwithalowerincidenceofrecurrence.Studieshaveshownthatthedisease-freesurvivalrateishigheramongpatientswhoundergothistypeofsurgery.Thisisbecausetheprocedureislessinvasiveandresultsinlessdamagetothesurroundingtissue.Moreover,surgeonsarebetterabletoassesstheextentofthetumorusingminimallyinvasivetechniques,whichmayreducetheriskthatanycanceroustissueisleftbehind.

Inconclusion,minimallyinvasivesurgeryforesophagealcancerisasafeandeffectivetreatmentoption.Ithasseveraladvantagesovertraditionalopensurgery,includingshorteroperationtime,reducedbleedingvolume,fewerlymphnodesremoved,shorterhospitalstay,andfasterrecoverytime.Moreover,thistypeofsurgeryisassociatedwithalowerincidenceofcomplications,improvedpatientqualityoflife,andahigherdisease-freesurvivalrate.Asaresult,itisimportantformedicalprofessionalstoconsidertheuseofminimallyinvasivesurgerywhentreatingpatientswithesophagealcancerEsophagealcancerisahighlymalignanttumorthathasapoorprognosis,withafive-yearsurvivalratethatrangesfrom15%to25%.Earlydiagnosisandtreatmentarethekeystoimprovingpatientoutcomes.Whiletraditionalopensurgeryhasbeenthestandardtreatmentforesophagealcancer,recentadvancementsinminimallyinvasivesurgicaltechniqueshaveshownpromiseinimprovingpatientoutcomes.

Minimallyinvasivesurgicaltechniquesrefertoavarietyofproceduresthatutilizesmallincisions,specializedinstruments,andadvancedimagingtechnologies,suchaslaparoscopyandthoracoscopy.Thesetechniquescanbeusedtoremovecanceroustissuefromtheesophaguswithlessdamagetothesurroundingtissues,resultinginshorteroperationtime,reducedbleedingvolume,fewerlymphnodesremoved,shorterhospitalstay,andfasterrecoverytime.

Oneminimallyinvasivesurgerytechniquethathasbeenincreasinglyusedinthetreatmentofesophagealcancerisrobot-assistedsurgery.Inthisprocedure,asurgeoncontrolsaroboticsurgicalsystemthatusesminiaturizedinstrumentsandahigh-resolutioncameratoperformthesurgery.Robot-assistedsurgeryoffersseveraladvantagesovertraditionalopensurgery,includinggreaterprecision,increasedrangeofmotion,andimprovedvisualizationofthesurgicalsite.

Anotherminimallyinvasivesurgicaltechniquethathasgainedpopularityinrecentyearsisendoscopicsubmucosaldissection(ESD).InESD,aflexibleendoscopeisusedtoremovecanceroustissuefromtheinnerliningoftheesophagus.Thistechniqueisespeciallyusefulintreatingearly-stageesophagealcancerthathasnotspreadbeyondtheinnerliningoftheesophagus.ESDhasbeenshowntohavealowerincidenceofcomplications,shorterhospitalstays,andfasterrecoverytimescomparedtotraditionalopensurgery.

Decreasedmorbidityandfasterrecoverytimeassociatedwithminimallyinvasivesurgeryhaveledtoanimprovementinpatientqualityoflife.Patientswhoundergominimallyinvasivesurgeryreportlesspain,lessscarring,andaquickerreturn

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論